Prescription practices in the treatment of first-episode schizophrenia spectrum disorders: data from the national RAISE-ETP study.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  American Journal of Psychiatry

• Publication date

  2015-03-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1176/appi.ajp.2014.13101355PMID 25727536PMCID PMC4358323
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis.

  2013cited by this paper
• World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 2: Update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects

  2013cited by this paper
• Metabolic and cardiovascular adverse effects associated with antipsychotic drugs

  2012cited by this paper
• Systematic review of early cardiometabolic outcomes of the first treated episode of psychosis.

  2011cited by this paper
• A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia.

  2011cited by this paper
• Targeted Intervention to Improve Monitoring of Antipsychotic-Induced Weight Gain and Metabolic Disturbance in First Episode Psychosis

  2011cited by this paper
• Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology

  2011cited by this paper
• The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements.

  2010cited by this paper
• Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents.

  2009cited by this paper
• Why We (Usually) Don't Have to Worry About Multiple Comparisons

  2009cited by this paper
• Changes Over Time and Disparities in Schizophrenia Treatment Quality

  2009cited by this paper
• A weakly informative default prior distribution for logistic and other regression models

  2008cited by this paper
• Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial.

  2008cited by this paper
• Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: a randomized, double-blind 52-week comparison.

  2007cited by this paper
• BMC Medicine BioMed Central

  2007cited by this paper
• Randomized comparison of olanzapine versus risperidone for the treatment of first-episode schizophrenia: 4-month outcomes.

  2006cited by this paper
• Clinical practice guidelines. Treatment of schizophrenia.

  2005cited by this paper
• Patient characteristics and the likelihood of initiation on olanzapine or risperidone among patients with schizophrenia.

  2005cited by this paper
• Pharmacological treatments for first-episode schizophrenia.

  2005cited by this paper
• Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial.

  2005cited by this paper
• A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology

  2004cited by this paper
• The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2006 update.

  2004cited by this paper
• Gender differences in the prescribing of antipsychotic drugs.

  2004cited by this paper
• Variations in use of second-generation antipsychotic medication by race among adult psychiatric patients.

  2004cited by this paper
• Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol.

  2003cited by this paper
• Outpatient prescriptions for atypical antipsychotics for African Americans, Hispanics, and whites in the United States.

  2003cited by this paper
• Racial disparities in antipsychotic prescription patterns for patients with schizophrenia.

  2002cited by this paper
• Smoking in Patients Receiving Psychotropic Medications

  2001cited by this paper
• Variable selection and Bayesian model averaging in case‐control studies

  2001cited by this paper
• Structured Clinical Interview for DSM-IV Axis I Disorders

  1997influential reference
• Bayes factors

  1995cited by this paper
• The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire.

  1991cited by this paper
• Partial Separation in Logistic Discrimination

  1989cited by this paper
• On the existence of maximum likelihood estimates in logistic regression models

  1984cited by this paper

• Prescription Patterns of Antipsychotics in Schizophrenia: Influence of Symptom Predominance and Clinical Global Impression Scale

  2025cites this paper
• The EnTRy Program: Expanding Coordinated Specialty Care Beyond Early Psychosis

  2025cites this paper
• Changes in glutamate levels in anterior cingulate cortex following 16 weeks of antipsychotic treatment in antipsychotic-naïve first-episode psychosis patients

  2025cites this paper
• Higher-Order Intrinsic Brain Network Trajectories after Antipsychotic Treatment in Medication-Naïve First Episode Psychosis Patients.

  2024cites this paper
• Collaborative care approaches for people with severe mental illness

  2024cites this paper
• Sleep Problems, Suicidal Ideation, and Psychopathology in First-Episode Psychosis.

  2023cites this paper
• Racism and Social Determinants of Psychosis.

  2023cites this paper
• Patient Attitudes Toward Pharmacogenetic Testing in Psychiatric Treatment

  2023cites this paper
• Understanding the Health System Conditions Affecting the Use of Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia in Clinical Practice: A US Healthcare Provider Survey

  2022cites this paper
• Two-year cohort-up study of clozapine prescription in Chinese patients with schizophrenia treated in rural primary care.

  2022cites this paper
• Development of the First Episode Digital Monitoring mHealth Intervention for People With Early Psychosis: Qualitative Interview Study With Clinicians

  2022cites this paper
• FiRst EpisodE Digital Monitoring (FREEDoM): A Qualitative Study to Inform the Development of a Novel mHealth Intervention for People with Early Psychosis (Preprint)

  2022cites this paper
• Clinical and psychosocial outcomes of Black Americans in the Recovery After an Initial Schizophrenia Episode Early Treatment Program (RAISE-ETP) study

  2022cites this paper
• The pharmacological treatment of schizophrenia: How far have we come?

  2022cites this paper
• Care Pathways, Health Service Use Patterns and Opportunities for Justice Involvement Prevention Among Forensic Mental Health Clients

  2022cites this paper
• Spiritual emergence(y), psychosis, and personality: Investigating the role of schizotypy.

  2022cites this paper
• Pharmacotherapy of Schizophrenia in Acute and Maintenance Phase

  2021cites this paper
• Racial and ethnic disparities in research and treatment of people with schizophrenia

  2021cites this paper
• Structural and Functional Default Mode Network Connectivity and Antipsychotic Treatment Response in Medication-Naïve First Episode Psychosis Patients

  2021cites this paper
• Comparison of Black and white individuals who report diagnoses of schizophrenia in a national sample of US adults: Discrimination and service use.

  2021cites this paper
• Racial and ethnic disparities in research and treatment of people with schizophrenia.

  2021cites this paper
• Prescribing pattern of antipsychotic medication for first-episode psychosis: a retrospective cohort study

  2021cites this paper
• Treatment Principles of First-Episode Psychosis

  2021cites this paper
• Prescribing differently for women with first-episode psychosis

  2021cites this paper
• Effects of Repetitive Transcranial Magnetic Stimulation on Working Memory Performance and Brain Structure in People With Schizophrenia Spectrum Disorders: A Double-Blind, Randomized, Sham-Controlled Trial.

  2020cites this paper
• Clozapine Use in Patients with Early-Stage Schizophrenia in a Chinese Psychiatric Hospital

  2020cites this paper
• Using Claims Data to Assess Treatment Quality of First-Episode Psychosis.

  2020cites this paper
• National Institute of Mental Health

  2020cites this paper
• Specialised early intervention teams (extended time) for recent-onset psychosis.

  2020cites this paper
• Specialised early intervention teams for recent-onset psychosis.

  2020cites this paper
• NDT_A_261503 2827..2836

  2020cites this paper
• Drug‐naïve first‐episode schizophrenia spectrum disorders: Pharmacological treatment practices in inpatient units in Hunan Province, China

  2020influential citation
• Constructing Instrument Mapping Using Markov Boundary Techniques: A Case Study with Two Quality of Life Instruments

  2019cites this paper
• A potential role for adjunctive omega-3 polyunsaturated fatty acids for depression and anxiety symptoms in recent onset psychosis: Results from a 16 week randomized placebo-controlled trial for participants concurrently treated with risperidone.

  2019cites this paper
• A longitudinal magnetic resonance spectroscopy study investigating effects of risperidone in the anterior cingulate cortex and hippocampus in schizophrenia.

  2019cites this paper
• Citalopram in first episode schizophrenia: The DECIFER trial.

  2019cites this paper
• Micro- and Macrostructural White Matter Integrity in Never-Treated and Currently Unmedicated Patients With Schizophrenia and Effects of Short-Term Antipsychotic Treatment.

  2019cites this paper
• A new selective carbon paste electrode for potentiometric analysis of olanzapine

  2019cites this paper
• A New Method for Estimating Incidence of First Psychotic Diagnosis in a Medicaid Population.

  2019cites this paper
• Prescription practices in the treatment of agitation in newly hospitalized Chinese schizophrenia patients: data from a non-interventional naturalistic study

  2019cites this paper
• Long-term efficacy and safety of paliperidone palmitate once-monthly in Chinese patients with recent-onset schizophrenia

  2019cites this paper
• An open-label randomised comparison of aripiprazole, olanzapine and risperidone for the acute treatment of first-episode schizophrenia: Eight-week outcomes

  2019cites this paper
• Interventions for prodromal stage of psychosis.

  2019cites this paper
• The Predicted Long-Term Benefits of Ensuring Timely Treatment and Medication Adherence in Early Schizophrenia

  2019cites this paper
• Predictors of psychosis breakthrough during 24 months of long-acting antipsychotic maintenance treatment in first episode schizophrenia.

  2019cites this paper
• New discoveries for an old drug: a review of recent olanzapine research

  2019cites this paper
• NDT_A_191803 1685..1694

  2019cites this paper
• Racial Disparities in First-Episode Psychosis Treatment Outcomes from the RAISE-ETP Study

  2019cites this paper
• Non-invasive brain stimulation for the treatment of the negative symptoms in Schizophrenia: results from an updated systematic review and a meta-analysis

  2018cites this paper
• Assessment of Drug Therapy Problems and Associated Factors Among Ambulatory Patients with Schizophrenia at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia: A Cross-Sectional Study

  2018cites this paper
• No differences in olanzapine‐ and risperidone‐related weight gain between women and men: a meta‐analysis of short‐ and middle‐term treatment

  2018cites this paper
• Comparison of Olanzapine versus Other Second-Generation Antipsychotics in the Improvement of Insight and Medication Discontinuation Rate in Schizophrenia

  2018cites this paper
• Dose reduction of risperidone and olanzapine can improve cognitive function and negative symptoms in stable schizophrenic patients: A single-blinded, 52-week, randomized controlled study

  2018cites this paper
• Transforming the Treatment of Schizophrenia in the United States: The RAISE Initiative.

  2018cites this paper
• Incidence and predictors of acute akathisia in severely ill patients with first-episode schizophrenia treated with aripiprazole or risperidone: secondary analysis of an observational study

  2018cites this paper
• Racial-Ethnic Disparities in First-Episode Psychosis Treatment Outcomes From the RAISE-ETP Study.

  2018cites this paper
• Five Year Outcomes of Tapering Antipsychotic Drug Doses in a Community Mental Health Center

  2018cites this paper
• Continue, adjust, or stop antipsychotic medication: developing and user testing an encounter decision aid for people with first-episode and long-term psychosis

  2018cites this paper
• The Potential of Cannabidiol Treatment for Cannabis Users With Recent-Onset Psychosis.

  2018cites this paper
• Simulated long‐term outcomes of early use of long‐acting injectable antipsychotics in early schizophrenia

  2018cites this paper
• Genderwise clinical response of antipsychotics among schizophrenic patients: a prospective observational study from Lahore, Pakistan

  2018cites this paper
• Non-invasive brain stimulation for negative symptoms in schizophrenia: An updated systematic review and meta-analysis.

  2018cites this paper
• Anticholinergic use trends in 14,013 patients with schizophrenia from three national surveys on the use of psychotropic medications in China (2002-2012).

  2017cites this paper
• Neuromodulação em esquizofrenia: estimulação elétrica cerebral e neurofeedback hemoencefalográfico

  2017cites this paper
• Prescribing pattern of clozapine and other antipsychotics for patients with first-episode psychosis: a cross-sectional survey of early intervention teams

  2017cites this paper
• Psychopharmacological Treatment in the RAISE-ETP Study: Outcomes of a Manual and Computer Decision Support System Based Intervention.

  2017cites this paper
• Gender Medicine and Pharmacoeconomics: A Narrative Review of the International Literature of the Last 5 Years. A Revision of Evidences about the Relationship Between Gender and Economic Consumption in Health.

  2017cites this paper
• Introduction to Magellan ’ s Adopted Clinical Practice Guidelines For the Treatment of Schizophrenia

  2017influential citation
• N-acetylcysteine in a Double-Blind Randomized Placebo-Controlled Trial: Toward Biomarker-Guided Treatment in Early Psychosis

  2017cites this paper
• Pharmacological guidelines for schizophrenia: a systematic review and comparison of recommendations for the first episode

  2017cites this paper
• Twelve-Month Health Care Use and Mortality in Commercially Insured Young People With Incident Psychosis in the United States

  2017cites this paper
• Demographic, psychosocial, clinical, and neurocognitive baseline characteristics of Black Americans in the RAISE-ETP study.

  2017cites this paper
• Duration of untreated psychosis and acute remission of negative symptoms in a South American first‐episode psychosis cohort

  2017cites this paper
• The Impact of the Sensory Integration Approach on Positive and Negative Symptoms in a Patient With Non-Paranoid Schizophrenia: A Case Report

  2016cites this paper
• Incident users of antipsychotics: who are they and how do they fare?

  2016cites this paper
• Correlates of Clozapine Use after a First Episode of Schizophrenia: Results From a Long-term Prospective Study

  2016cites this paper
• The RAISE Connection Program: Psychopharmacological Treatment of People With a First Episode of Schizophrenia.

  2016cites this paper
• Implementation of treatment guidelines for specialist mental health care.

  2016cites this paper
• Cost-Effectiveness of Comprehensive, Integrated Care for First Episode Psychosis in the NIMH RAISE Early Treatment Program.

  2016cites this paper
• The Psychology of Schizophrenia: Implications for Biological and Psychotherapeutic Treatments

  2016cites this paper
• Comprehensive Versus Usual Community Care for First-Episode Psychosis: 2-Year Outcomes From the NIMH RAISE Early Treatment Program.

  2016cites this paper
• [A model of care for first-episode psychosis: the RAISE-ETP project].

  2016cites this paper
• Using early antipsychotic response to predict treatment outcome in patients with first-episode psychosis

  2016cites this paper
• Frühdiagnostik und -behandlung der Schizophrenie

  2016cites this paper
• A Randomized Comparison of Aripiprazole and Risperidone for the Acute Treatment of First-Episode Schizophrenia and Related Disorders: 3-Month Outcomes.

  2015cites this paper
• Prescriber training needed for first‐episode psychosis in schizophrenia

  2015cites this paper
• Evidence-based medicine and clinical expertise.

  2015cites this paper
• Recommendations for the monitoring of serum concentrations of antipsychotic drugs in the treatment of schizophrenia.

  2015cites this paper
• Kaleidoscope

  2015cites this paper
• A Pharmacovigilance Study in First Episode of Psychosis: Psychopharmacological Interventions and Safety Profiles in the PEPs Project

  2015cites this paper
• Evidence-Based Medicine and Clinical Expertise

  2015cites this paper
• Rationale and Evidence for Nonstandard First-Line Treatments for Schizophrenia: Consider Long-Acting Injectable Antipsychotics; Use Clozapine as Second- or Third-Line Therapy Only

  2015cites this paper
• The NAVIGATE Program for First-Episode Psychosis: Rationale, Overview, and Description of Psychosocial Components.

  2015cites this paper
• A UPLC-MSMS method for the analysis of olanzapine in serum-with particular emphasis on drug stability testing.

  2015cites this paper
• Promoting physical health for people with schizophrenia by reducing disparities in medical and dental care

  2015cites this paper
• Medications for first-episode psychosis: making a good start.

  2015cites this paper
• Implementation of treatment guidelines for specialist mental health care.

  2014cites this paper
• Spiritual Emergence(y), Psychosis, and Personality: Investigating Spiritual Emergence(y), Psychosis, and Personality: Investigating the Role of Schizotypy the Role of Schizotypy

  year unknowncites this paper